Skadden, Latham act on $1.1 bln Japan outbound pharma deal
BY Asian Legal Business《亚洲法律杂志》 |
Skadden, Arps, Slate, Meagher & Flom has advised Japan's Otsuka Pharmaceutical on its $1.1 billion agreement to acquire Boston-based Jnana Therapeutics, which was represented by Latham & Watkins.